Haisong Lin

Dr. Haisong Lin

Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Science Advances
Verified
Journal Article
Open access
BWBo Wang
Bo Wang
CZChuanzhen Zhao
Chuanzhen Zhao
ZWZhaoqing Wang
Zhaoqing Wang
KYKyung-Ae Yang
Kyung-Ae Yang
XCXuanbing Cheng
Xuanbing Cheng
SESam Emaminejad
Sam Emaminejad
A smartwatch was developed for noninvasive stress biomarker data acquisition that provides real-time feedback to the wearer.

1 November 2019 in Biomicrofluidics
Verified
Journal Article
Open access
PDF file
CYChristopher Yeung
Christopher Yeung
SCShawnus Chen
Shawnus Chen
BKBrian King
Brian King
HLHaisong Lin
Haisong Lin
KKKimber King
Kimber King
SESam Emaminejad
Sam Emaminejad
Embedding microfluidic architectures with microneedles enables fluid management capabilities that present new degrees of freedom for transdermal drug delivery. To this end, fabrication schemes that can simultaneously create and integrate complex millimeter/centimeter-long microfluidic structures and micrometer-scale microneedle features are necessary. Accordingly, three-dimensional (3D) printing techniques are suitable candidates because they allow the rapid realization of customizable yet intricate microfluidic and microneedle features. However, previously reported 3D-printing approaches utilized costly instrumentation that lacked the desired versatility to print both features in a single step and the throughput to render components within distinct length-scales. Here, for the first time in literature, we devise a fabrication scheme to create hollow microneedles interfaced with microfluidic structures in a single step. Our method utilizes stereolithography 3D-printing and pushes its boundaries (achieving print resolutions below the full width half maximum laser spot size resolution) to create complex architectures with lower cost and higher print speed and throughput than previously reported methods. To demonstrate a potential application, a microfluidic-enabled microneedle architecture was printed to render hydrodynamic mixing and transdermal drug delivery within a single device. The presented architectures can be adopted in future biomedical devices to facilitate new modes of operations for transdermal drug delivery applications such as combinational therapy for preclinical testing of biologic treatments.

2 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHaisong Lin
Haisong Lin
JTJiawei Tan
Jiawei Tan
JZJialun Zhu
Jialun Zhu
SLShuyu Lin
Shuyu Lin
YZYichao Zhao
Yichao Zhao
SESam Emaminejad
Sam Emaminejad
Active biofluid management is central to the realization of wearable bioanalytical platforms that are poised to autonomously provide frequent, real-time, and accurate measures of biomarkers in epidermally-retrievable biofluids (e.g., sweat). Accordingly, here, a programmable epidermal microfluidic valving system is devised, which is capable of biofluid sampling, routing, and compartmentalization for biomarker analysis. At its core, the system is a network of individually-addressable microheater-controlled thermo-responsive hydrogel valves, augmented with a pressure regulation mechanism to accommodate pressure built-up, when interfacing sweat glands. The active biofluid control achieved by this system is harnessed to create unprecedented wearable bioanalytical capabilities at both the sensor level (decoupling the confounding influence of flow rate variability on sensor response) and the system level (facilitating context-based sensor selection/protection). Through integration with a wireless flexible printed circuit board and seamless bilateral communication with consumer electronics (e.g., smartwatch), contextually-relevant (scheduled/on-demand) on-body biomarker data acquisition/display was achieved.

20 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
YZYichao Zhao
Yichao Zhao
BWBo Wang
Bo Wang
HHHannaneh Hojaiji
Hannaneh Hojaiji
ZWZhaoqing Wang
Zhaoqing Wang
SLShuyu Lin
Shuyu Lin
SESam Emaminejad
Sam Emaminejad
We devised a strategy for high-fidelity, wearable biomarker data acquisition and sensor integration with consumer electronics.

26 February 2020 in Science Robotics
Verified
Journal Article
Closed access
PDF file
WYWenzhuo Yu
Wenzhuo Yu
HLHaisong Lin
Haisong Lin
YWYilian Wang
Yilian Wang
XHXu He
Xu He
NCNathan Chen
Nathan Chen
SESam Emaminejad
Sam Emaminejad
A ferrobotic system is devised to implement diverse, efficient, and automated microfluidic logistics.

27 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLShuyu Lin
Shuyu Lin
WYWenzhuo Yu
Wenzhuo Yu
BWBo Wang
Bo Wang
YZYichao Zhao
Yichao Zhao
KEKe En
Ke En
SESam Emaminejad
Sam Emaminejad
To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. In that regard, wearable biosensing technologies, capable of tracking drug pharmacokinetics in noninvasively retrievable biofluids (e.g., sweat), play a critical role, because they can be deployed at a large scale to monitor the individuals’ drug transcourse profiles (semi)continuously and longitudinally. To this end, voltammetry-based sensing modalities are suitable, as in principle they can detect and quantify electroactive drugs on the basis of the target’s redox signature. However, the target’s redox signature in complex biofluid matrices can be confounded by the immediate biofouling effects and distorted/buried by the interfering voltammetric responses of endogenous electroactive species. Here, we devise a wearable voltammetric sensor development strategy—centering on engineering the molecule–surface interactions—to simultaneously mitigate biofouling and create an “undistorted potential window” within which the target drug’s voltammetric response is dominant and interference is eliminated. To inform its clinical utility, our strategy was adopted to track the temporal profile of circulating acetaminophen (a widely used analgesic and antipyretic) in saliva and sweat, using a surface-modified boron-doped diamond sensing interface (cross-validated with laboratory-based assays, R2 ∼ 0.94). Through integration of the engineered sensing interface within a custom-developed smartwatch, and augmentation with a dedicated analytical framework (for redox peak extraction), we realized a wearable solution to seamlessly render drug readouts with minute-level temporal resolution. Leveraging this solution, we demonstrated the pharmacokinetic correlation and significance of sweat readings. Significance To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. By devising a surface engineering strategy, we created a voltammetric sensing interface, featuring an “undistorted potential window,” within which the target electroactive drug’s voltammetric response is dominant and interference is eliminated, rendering reliable target quantification in noninvasively retrievable biofluids (sweat and saliva). Leveraging this sensing interface, a fully integrated, wearable solution was constructed to seamlessly render drug readouts with minute-level temporal resolution. To inform its clinical utility, the solution was utilized to demonstrate noninvasive pharmacokinetic monitoring of a pharmaceutical (here, acetaminophen, a widely used analgesic and antipyretic) in a wearable format.